cabozantinib - Robuta Search

https://adisinsight.springer.com/trials/700202044?error=cookies_not_supported&code=9853d10e-ff6a-44d3-b9fa-d24e72267b97 A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone... This pivotal trial is evaluating the efficacy and tolerability of cabozantinib [XL 184; Exelixis], compared with mitoxantrone plus prednisone, as second-line https://pubmed.ncbi.nlm.nih.gov/31558480/?otool=flbhsflib&holding=flbhsflib Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus... MET/VEGFR blockade with cabozantinib demonstrated no improvement in PFS but an increase in toxicity relative to temozolomide/dacarbazine in metastatic uveal... phase ii https://adisinsight.springer.com/trials/700366825?error=cookies_not_supported&code=f48f8819-5f29-4a00-ba15-13f281536f48 Randomized Phase 2 Study of Nivolumab and Ipilimumab With or Without Cabozantinib in Patients With... This phase II trial tests how well nivolumab and ipilimumab immunotherapy with or without cabozantinib in treating patients with nasopharyngeal cancer that has https://adisinsight.springer.com/drugsafety/803876431?error=cookies_not_supported&code=3a838978-ca88-4996-9a59-cba4923fc0ef Cabozantinib/Nivolumab - AdisInsight A 56-year-old man developed Hashimoto's thyroiditis during treatment with cabozantinib and nivolumab for right renal cell carcinoma [routes, dosages, duration cabozantinib nivolumab adisinsight https://pubmed.ncbi.nlm.nih.gov/37017710/ Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell... Tailoring treatment with pazopanib and cabozantinib was associated with better PFS/OS. in patients tailoring treatment cabozantinib https://www.cancer.gov/news-events/cancer-currents-blog/2021/papillary-renal-cell-carcinoma-cabozantinib Cabozantinib Slows Progression of Rare Kidney Cancer - NCI The targeted drug cabozantinib (Cabometyx) is effective for some people with papillary renal cell carcinoma (PRCC), a rare type of kidney cancer. In a clinical... kidney cancer cabozantinib slows progression rare https://clinicaltrials.med.nyu.edu/cancer/clinicaltrial/2442/randomized-phase-ii-trial/?qd=39056991 A RANDOMIZED PHASE II TRIAL OF ADJUVANT NIVOLUMAB WITH OR WITHOUT CABOZANTINIB IN PATIENTS WITH... New life-saving treatments for Mucosal Melanoma|resected or non resected mucosal melanoma in clinical trial on A RANDOMIZED PHASE II TRIAL OF ADJUVANT... https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2018-01041&r=1 Cabozantinib or Sunitinib Malate in Treating Participants with Metastatic Variant Histology Renal... Cabozantinib or Sunitinib Malate in Treating Participants with Metastatic Variant Histology Renal Cell Carcinoma https://jcto.weill.cornell.edu/open_clinical_trials/phase-ii-study-of-cabozantinib-in-combination-with-nivolumab-and-ipilimumab-in-rare-genitourinary-tumors Phase II Study of Cabozantinib in Combination with Nivolumab and Ipilimumab in Rare Genitourinary... The purpose of this study is to test the effectiveness of the drugs cabozantinib with nivolumab and ipilimumab in rare genitourinary (GU) cancers that have no... https://scholars.duke.edu/publication/1279482 Scholars@Duke publication: Phase II study of cabozantinib in patients with progressive... phase ii https://pubmed.ncbi.nlm.nih.gov/33477676/ Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New... We analyzed the clinical and pathological features of renal cell carcinoma (RCC) patients treated with cabozantinib stratified by body mass index (BMI). We... https://adisinsight.springer.com/drugsafety/803927607?error=cookies_not_supported&code=409d80aa-992f-4da1-800e-305d52cf774e Cabozantinib/Temozolomide - AdisInsight Thirty-seven patients [sex and ages not stated] with well-differentiated neuroendocrine tumours at an advanced, progressive stage involving gastrointestinal, cabozantinib temozolomide adisinsight https://pubmed.ncbi.nlm.nih.gov/28974985/ Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential Since the advent of immunotherapy revolutionized the treatment of metastatic renal cell carcinoma (mRCC), the attention of oncologists has been unavoidably... renal cell carcinoma latest findings cabozantinib metastatic https://adisinsight.springer.com/drugsafety/803864125?error=cookies_not_supported&code=0d1e1dc2-2457-4fe8-9e66-31b5215138b2 Cabozantinib - AdisInsight In a multicenter, retrospective, international cohort study, involving 52 patients, conducted between December 2011 and December 2020, 2 patients [ages and cabozantinib adisinsight https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT03141177&r=1 A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated... A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma https://scholars.uky.edu/en/projects/phase-ii-clinical-trial-evaluating-cabozantinib-and-pembrolizumab-4/ Phase II Clinical Trial Evaluating Cabozantinib and Pembrolizumab in Second-Line Therapy for... https://pubmed.ncbi.nlm.nih.gov/27462141/ Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential... The treatment of metastatic renal cell carcinoma (mRCC) has markedly improved over the last few years with the introduction of several targeted agents in... renal cell carcinoma https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT03690388&r=1 A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory... A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular... a study cabozantinib compared